December 16, 2025 - Health Technology Insights

December 16, 2025
HealthTech Media Room
HealthTech News, News, news

Form Health Offers Clear, Predictable GLP-1 Coverage for Employers

Form Is Removing Uncertainty From GLP-1 Coverage, Helping Employers Manage Medication Costs While Supporting Employee Health Form Health, the national leader in science-based obesity and cardiometabolic care, announced access...

December 16, 2025
HealthTech Media Room
HealthTech News, News, news

MediBeacon Next Generation TGFR System Receives FDA Approval

Centers of Excellence commercialization in select academic medical centers begins in early 2026 INNOVATE Corp. that MediBeacon Inc. , a medical technology company specializing in the advancement of fluorescent...

December 16, 2025
HealthTech Media Room
HealthTech News, News, news

Cofactor Genomics Secures Strategic Investment from Labcorp

Cofactor Genomics, a commercial-stage diagnostics company transforming precision oncology through RNA-based predictive tests, announced strategic investments from Labcorp and Ascension Ventures. The financing is intended to accelerate Cofactor’s nationwide expansion and broaden...

December 16, 2025
HealthTech Staff Writer
HealthTech News, News, news

Valcadia Advises CURC on Acquisition by START Center

Valcadia Healthcare Partners a leading healthcare investment banking and M&A advisory firm, announced that it has advised Carolina Urologic Cancer Center, the premier urologic clinical research site specializing in...

December 16, 2025
HealthTech Staff Writer
AI in Healthcare, Featured

AWS Expands Cloud and AI Capabilities for Healthcare Providers

Healthcare‍‌‍‍‌‍‌‍‍‌ executives are rarely technology-driven. They only make such investments when technology can lead to better care, be more trustworthy, and bring about better outcomes. This is the main...

December 16, 2025
HealthTech Media Room
HealthTech News, News, news, Pharmaceuticals, Women Health

ENHERTU Plus Pertuzumab Approved for HER2+ Breast Cancer

Based on DESTINY-Breast09 phase 3 trial results that showed Daiichi Sankyo and AstraZeneca’s ENHERTU in combination with pertuzumab reduced the risk of disease progression by 44% versus THP with...

December 16, 2025
HealthTech Media Room
HealthTech News, News, news

OmniAb Launches OmniUltra to Expand Antibody Discovery Reach

First and only transgenic chicken platform engineered to express ultralong CDRH3 domains on a human antibody framework broadens therapeutic opportunities beyond conventional antibodies OmniAb, Inc. announces the launch of its...

December 16, 2025
HealthTech Media Room
HealthTech News, News, news

GenSci and RTW Partner on GS-098 for Graves’ and Eye Disease

Collaboration to focus on building a leading, US-based biotech dedicated to addressing underserved patients impacted by autoimmune and endocrinology disorders Shanghai Scizeng Medical Technology Co., LTD, a subsidiary of...

December 16, 2025
HealthTech Media Room
HealthTech News, News, news

Hercules Pharmaceuticals Appoints Ali Ahmed as Chief Commercial Officer

Hercules Pharmaceuticals announced the appointment of Ali Ahmed as Executive Vice President, Chief Commercial Officer. Ahmed will lead commercial strategy, enterprise growth, and strategic partnerships as Hercules scales its national platform and...

December 16, 2025
HealthTech Media Room
AI in Healthcare, HealthTech News, News, news

MindWalk Achieves Record Growth and Advances AI Asset Pipeline

MindWalk, a bio-native AI research and biotherapeutics technology company that combines in silico and wet lab operations for biologic discovery and development, announced its financial results for the second quarter of...

December 16, 2025
HealthTech Media Room
HealthTech News, News, news

32BJ Health Fund, Northwell Direct Announce Landmark Healthcare Deal

32BJ Health Fund, the union health fund representing 100,000 building service workers in the New York metro area, and Northwell Direct, a direct-to-employer health care network that partners directly...

December 16, 2025
Archak Chakravorty
Uncategorized

Signatera Predicts Treatment Response in Early Breast Cancer

Natera, Inc., a leading company in cell-free DNA and precision medicine, announced in collaboration with Quantum Leap Healthcare Collaborative that new findings from the I-SPY 2 trial have been...